MAGEA1 and melanoma: Quantitative real-time RT-PCR analyses were performed to investigate and compare levels of CTA (i.e., NY-ESO-1, MAGE-A3, and MAGE-A1) expression induced by the different DHAs treatments, in CTA-negative tumor cells selected among the investigated 14 human melanoma and 10 human hematological cancer cell lines.